Design of semisynthetic derivatives of the Amaryllidaceae alkaloid ambelline and exploration of their in vitro cytotoxic activities
Status PubMed-not-MEDLINE Jazyk angličtina Země Saúdská Arábie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
37457365
PubMed Central
PMC10345363
DOI
10.1016/j.jsps.2023.06.017
PII: S1319-0164(23)00176-7
Knihovny.cz E-zdroje
- Klíčová slova
- 11-O-(4-Chloro-3-nitrobenzoyl)ambelline, Amaryllidaceae alkaloids, Ambelline, Antiproliferative activity, Cytotoxicity, In vitro,
- Publikační typ
- časopisecké články MeSH
Ambelline, an alkaloid from the Amaryllidaceae family with a crinane-type skeleton, has not yet demonstrated any outstanding biological activity. However, its analogues prepared by derivatization of the C-11 hydroxyl group show different interesting effects. Continuing our earlier work, twelve novel aromatic esters were developed (10, 14, 16, 17, 22-25, 30-33) and studied, together with previously synthesized derivatives (2-9, 11-13, 15, 18-21, 26-29) in terms of their cytotoxic activity. The cytotoxic potential was determined on a panel of nine human cancer cell lines and one noncancerous cell line to characterize their biological activity spectrum. To describe and foresee the structure-activity relationship for further research, substances synthesized and described in our previous work were also included in this cytotoxicity study. The most significant activity was associated with analogues having methyl (10), methoxy (14-17), or ethoxy (18) substitution on the phenyl condensed to ambelline. However, the 4-chloro-3-nitrobenzoyl derivative (32) showed the most promising IC50 values, ranging from 0.6 ± 0.1 µM to 9.9 ± 0.2 µM. In vitro cytotoxicity studies indicated the most potent antiproliferative activity of 32 in a dose-dependent and time-dependent manner. Besides, 32 was found to be effective in decreasing viability and triggering apoptosis of MOLT-4 T-lymphoblastic leukemia cells.
Zobrazit více v PubMed
Baig S., Seevasant I., Mohamad J., et al. Potential of apoptotic pathway-targeted cancer therapeutic research: where do we stand? Cell Death Dis. 2016;7 doi: 10.1038/cddis.2015.275. PubMed DOI PMC
Berkov S., Romani S., Herrera M., et al. Antiproliferative alkaloids from Crinum zeylanicum. Phytother Res. 2011;25:1686–1692. doi: 10.1002/ptr.3468. PubMed DOI
Cahlikova L., Kawano I., Rezacova M., et al. The Amaryllidaceae alkaloids haemanthamine, haemanthidine and their semisynthetic derivatives as potential drugs. Phytochem Rev. 2021;20:303–323. doi: 10.1007/s11101-020-09675-8. DOI
Campbell W.E., Nair J.J., Gammon D.W., et al. Cytotoxic and antimalarial alkaloids from Brunsvigia littoralis. Planta Med. 1998;64:91–93. doi: 10.1055/s-2006-957381. PubMed DOI
Cao Z.F., Yang P., Zhou Q.S. Multiple biological functions and pharmacological effects of lycorine. Sci. China Chem. 2013;56:1382–1391. doi: 10.1007/s11426-013-4967-9. PubMed DOI PMC
Choudhari A.S., Mandave P.C., Deshpande M., et al. Phytochemicals in cancer treatment: from preclinical studies to clinical practice (vol 10, 1614, 2020) Front. Pharmacol. 2020;11 doi: 10.3389/fphar.2020.00175. PubMed DOI PMC
Cragg G.M., Pezzuto J.M. Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents. Med. Prin. Pract. 2016;25:41–59. doi: 10.1159/000443404. PubMed DOI PMC
Ding Y., Qu D., Zhang K.M., et al. Phytochemical and biological investigations of Amaryllidaceae alkaloids: a review. J. Asian Nat. Prod. Res. 2017;19:53–100. doi: 10.1080/10286020.2016.1198332. PubMed DOI
Doskocil I., Hostalkova A., Safratova M., et al. Cytotoxic activities of Amaryllidaceae alkaloids against gastrointestinal cancer cells. Phytochem. Lett. 2015;13:394–398. doi: 10.1016/j.phytol.2015.08.004. DOI
Ferlay J., Colombet M., Soerjomataram I., et al. Cancer statistics for the year 2020: an overview. Int. J. Cancer. 2021 doi: 10.1002/ijc.33588. PubMed DOI
Furst R. Narciclasine - an amaryllidaceae alkaloid with potent antitumor and anti-inflammatory properties. Planta Med. 2016;82:1389–1394. doi: 10.1055/s-0042-115034. PubMed DOI
Guichard N., Guillarme D., Bonnabry P., et al. Antineoplastic drugs and their analysis: a state of the art review. Analyst. 2017;142:2273–2321. doi: 10.1039/c7an00367f. PubMed DOI
Habartova K., Cahlikova L., Rezacova M., et al. The biological activity of alkaloids from the Amaryllidaceae: from Cholinesterases inhibition to anticancer activity. Nat Prod Commun. 2016;11:1587–1594. doi: 10.1177/1934578X1601101038. PubMed DOI
Hanh T.T.H., Anh D.H., Huong P.T.T., et al. Crinane, augustamine, and beta-carboline alkaloids from Crinum latifolium. Phytochem Lett. 2018;24:27–30. doi: 10.1016/j.phytol.2018.01.004. DOI
Havelek R., Seifrtova M., Kralovec K., et al. The effect of Amaryllidaceae alkaloids haemanthamine and haemanthidine on cell cycle progression and apoptosis in p53-negative human leukemic Jurkat cells. Phytomedicine. 2014;21:479–490. doi: 10.1016/j.phymed.2013.09.005. PubMed DOI
Havelek R., Muthna D., Tomsik P., et al. Anticancer potential of Amaryllidaceae alkaloids evaluated by screening with a panel of human cells, real-time cellular analysis and Ehrlich tumor-bearing mice. Chem-Biol Interact. 2017;275:121–132. doi: 10.1016/j.cbi.2017.07.018. PubMed DOI
He M.M., Qu C.R., Gao O.D., et al. Biological and pharmacological activities of Amaryllidaceae alkaloids. Rsc Adv. 2015;5:16562–16574. doi: 10.1039/c4ra14666b. DOI
Likhitwitayawuid K., Angerhofer C.K., Chai H.B., et al. Traditional Medicinal-Plants of Thailand. 22. Cytotoxic and Antimalarial Alkaloids from the Bulbs of Crinum amabile. J. Nat. Prod. 1993;56:1331–1338. doi: 10.1021/np50098a017. PubMed DOI
Luchetti G., Johnston R., Mathieu V., et al. Bulbispermine: a crinine-type amaryllidaceae alkaloid exhibiting cytostatic activity toward apoptosis-resistant glioma cells. Chemmedchem. 2012;7:815–822. doi: 10.1002/cmdc.201100608. PubMed DOI PMC
Ma D., Pignanelli C., Tarade D., et al. Cancer cell mitochondria targeting by pancratistatin analogs is dependent on functional complex II and III. Sci Rep-Uk. 2017;7:42957. doi: 10.1038/srep42957. PubMed DOI PMC
Marikova J., Ritomska A., Korabecny J., et al. Aromatic Esters of the crinane amaryllidaceae alkaloid ambelline as selective inhibitors of butyrylcholinesterase. J. Nat. Prod. 2020;83:1359–1367. doi: 10.1021/acs.jnatprod.9b00561. PubMed DOI
Masi M., Di Lecce R., Merindol N., et al. Cytotoxicity and antiviral properties of alkaloids isolated from Pancratium maritimum. Toxins. 2022;14(4):262. doi: 10.3390/toxins14040262. PubMed DOI PMC
McNulty J., Nair J.J., Codina C., et al. Selective apoptosis-inducing activity of crinum-type Amaryllidaceae alkaloids. Phytochemistry. 2007;68:1068–1074. doi: 10.1016/j.phytochem.2007.01.006. PubMed DOI
McNulty J., Nair J.J., Bastida J., et al. Structure-activity studies on the lycorine pharmacophore: a potent inducer of apoptosis in human leukemia cells. Phytochemistry. 2009;70:913–919. doi: 10.1016/j.phytochem.2009.04.012. PubMed DOI PMC
Nair J.J., Bastida J., Codina C., et al. Alkaloids of the South African Amaryllidaceae: a review. Nat Prod Commun. 2013;8:1335–1350. doi: 10.1177/1934578X1300800938. PubMed DOI
Nair J.J., van Staden J. The Amaryllidaceae as a source of antiplasmodial crinane alkaloid constituents. Fitoterapia. 2019;134:305–313. doi: 10.1016/j.fitote.2019.02.009. PubMed DOI
Nair J.J., Bastida J., Viladomat F., et al. Cytotoxic agents of the crinane series of Amaryllidaceae alkaloids. Nat. Prod. Commun. 2012;7:1677–1688. doi: 10.1177/1934578X1200701234. PubMed DOI
Nair J.J., Bastida J., Viladomat F., et al. Cytotoxic agents of the crinane series of Amaryllidaceae alkaloids. Nat. Prod. Commun. 2013;8:553–564. doi: 10.1177/1934578X1200701234. PubMed DOI
Nair J.J., Rarova L., Strnad M., et al. Alkaloids from Boophone haemanthoides (Amaryllidaceae) Nat. Prod. Commun. 2013;8:1705–1710. doi: 10.1177/1934578X1300801211. PubMed DOI
Nair J.J., Rarova L., Strnad M., et al. Crinane alkaloids of the Amaryllidaceae with cytotoxic effects in human cervical adenocarcinoma (HeLa) cells. Nat. Prod. Commun. 2014;9:461–466. doi: 10.1177/1934578X1400900406. PubMed DOI
Nair J.J., Rarova L., Strnad M., et al. Mechanistic insights to the cytotoxicity of Amaryllidaceae alkaloids. Nat. Prod. Commun. 2015;10:171–182. doi: 10.1177/1934578X1501000138. PubMed DOI
Nair J.J., Bastida J., van Staden J. In vivo cytotoxicity studies of Amaryllidaceae alkaloids. Nat. Prod. Commun. 2016;11:121–132. doi: 10.1177/1934578X1601100134. PubMed DOI
Nair J.J., van Staden J. Cytotoxicity studies of lycorine alkaloids of the Amaryllidaceae. Nat. Prod. Commun. 2014;9:1193–1210. doi: 10.1177/1934578X1400900834. PubMed DOI
Nair J.J., Van Staden J., Bastida J. Cytotoxic alkaloid constituents of the Amaryllidaceae. Stud. Natural Products Chem. 2016;49:107–156. doi: 10.1016/B978-0-444-63601-0.00003-X. DOI
Pellegrino S., Meyer M., Zorbas C., et al. The Amaryllidaceae alkaloid haemanthamine binds the eukaryotic ribosome to repress cancer cell growth. Structure. 2018;26:416–425. doi: 10.1016/j.str.2018.01.009. PubMed DOI
Qing Z.X., Huang J.L., Yang X.Y., et al. Anticancer and reversing multidrug resistance activities of natural isoquinoline alkaloids and their structure-activity relationship. Curr. Med. Chem. 2018;25:5088–5114. doi: 10.2174/0929867324666170920125135. PubMed DOI
Seifrtova M., Havelek R., Cahlikova L., et al. Haemanthamine alters sodium butyrate-induced histone acetylation, p21(WAF1/Cip1) expression, Chk1 and Chk2 activation and leads to increased growth inhibition and death in A2780 ovarian cancer cells. Phytomedicine. 2017;35:1–10. doi: 10.1016/j.phymed.2017.08.019. PubMed DOI
Uher M., Hroch M., Perinova R., et al. Semisynthetic derivatives of haemanthamine and their in vitro antiproliferative activity evaluation against a panel of human cell lines. Arabian J. Chem. 2022;15 doi: 10.1016/j.arabjc.2022.103746. DOI
Vaneckova N., Hostalkova A., Safratova M., et al. Isolation of Amaryllidaceae alkaloids from Nerine bowdenii W. Watson and their biological activities. Rsc Adv. 2016;6:80114–80120. doi: 10.1039/c6ra20205e. DOI
Youssef D.T.A., Shaala L.A., Altyar A.E. Cytotoxic phenylpropanoid derivatives and alkaloids from the flowers of Pancratium maritimum L. Plants (Basel). 2022;11 doi: 10.3390/plants11040476. PubMed DOI PMC